Marshall Wace’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.19M Buy
237,656
+220,525
+1,287% +$4.43M ﹤0.01% 1386
2025
Q4
$338K Sell
17,131
-13,864
-45% -$249K ﹤0.01% 2405
2025
Q3
$541K Sell
30,995
-2,008,719
-98% -$29.8M ﹤0.01% 2203
2025
Q2
$28.6M Buy
2,039,714
+1,293,416
+173% +$20.8M 0.03% 452
2025
Q1
$13.9M Buy
+746,298
New +$11.1M 0.02% 646
2023
Q4
Sell
-456,270
Closed -$3.17M 2133
2023
Q3
$3.17M Sell
456,270
-375,448
-45% -$2.27M 0.01% 1032
2023
Q2
$4.78M Sell
831,718
-28,199
-3% -$182K 0.01% 1035
2023
Q1
$5.47M Sell
859,917
-244,752
-22% -$2.33M 0.01% 954
2022
Q4
$13M Sell
1,104,669
-1,777,690
-62% -$21.6M 0.03% 671
2022
Q3
$34.1M Buy
+2,882,359
New +$42.1M 0.07% 301
2022
Q1
Sell
-130,150
Closed -$1.83M 3298
2021
Q4
$1.83M Buy
+130,150
New +$2.28M ﹤0.01% 2095

Other funds holding ALHC

Marshall Wace's ALHC Position: Q1 2026 in Review

Marshall Wace increased its Alignment Healthcare (ALHC) stake by 1,287% in Q1 2026, buying an estimated $4.43M and bringing the position to 237,656 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Marshall Wace first reported a position in ALHC in Q4 2021 and has held it in 11 quarters since. The position peaked at $34.1M in Q3 2022. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Marshall Wace held 237,656 shares of Alignment Healthcare worth $4.19M as of Q1 2026.
  • Marshall Wace bought 220,525 Alignment Healthcare shares in Q1 2026, an estimated $4.43M.
  • Alignment Healthcare made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1386 holding.
  • Marshall Wace first reported a position in Alignment Healthcare in Q4 2021 and has held it in 11 quarters since.
  • Marshall Wace's Alignment Healthcare position peaked at $34.1M in Q3 2022.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.